# Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

> **NCT00183742** · PHASE1 · COMPLETED · sponsor: **University of Southern California** · enrollment: 35 (—)

## Conditions studied

- Cancer
- Carcinoma

## Interventions

- **DRUG:** liposomal doxorubicin and docetaxel

## Key facts

- **NCT ID:** NCT00183742
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** 2005-10
- **Final completion:** 2006-05
- **Target enrollment:** 35 (—)
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183742, "Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00183742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*